Clinical Trial Update: Evaluation of the Condition of Patients Receiving EARLY Ravulizumab and Admitted in ICU for gMG Crisis

View source ↗

Summary

A recruiting study is evaluating early ravulizumab administration in ICU-admitted patients with generalized Myasthenia Gravis crisis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis

Drugs mentioned

• Ravulizumab (ravulizumab)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Myasthenia Gravis | Status: RECRUITING